Human T-Lymphotropic Retroviruses and Their Role in Human Diseases

  • Robert C. Gallo
  • Flossie Wong-Staal
Part of the NATO ASI Series book series (NSSA, volume 120)


Information on a group of human retroviruses called Human T-lymphotropic Virus (HTLV) has rapidly amassed in the last few years (1). These are horizontally transmitted viruses which infect the subset of lymphocytes expressing helper function and the OKT4 marker. HTLV-I and HTLV-III are the etiologic agents of, respectively, adult T-cell leukemia (ATL) (2) and acquired immunodeficiency syndrome (AIDS) (3). Discovery of these viruses and the identification of their pathogenic roles represent the culmination of efforts in the preceeding decade directed at detection of retroviruses in humans, particularly in neoplasms of hematopoietic origin. In 1976, this laboratory identified a factor in the culture medium of mitogen-stimulated human lymphocytes which supported the long term growth of human T-cells (4). This factor, called T-cell growth factor or interleukin-2 (IL-2), was used to grow normal and neoplastic T-cells. Since normal T-cells required activation by mitogen or antigen to respond to IL-2 and T-cells from ATL patients responded directly to IL-2 without prior activation, it was possible to selectively grow neoplastic T-cells in culture and study them for the presence of retro-viruses. This led first to identification and isolation of HTLV-I from ATL patients. Subsequently, using a similar protocol, HTLV-II (5) was obtained from a patient with T-cell Hairy Cell leukemia. We later showed that HTLV-I and HTLV-II infected cells constitutively expressed high levels of IL-2 receptors.


Hairy Cell Leukemia Lymphoid Leukemia Chronic Lymphoid Leukemia Infectious Disease Ward Block Virus Replication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    F. Wong-Staal, and R. C. Gallo, Human T-lymphotropic retroviruses, Nature, 317: 395 (1985).PubMedCrossRefGoogle Scholar
  2. 2.
    B. J. Poiesz, F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo, Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc. Nat. Acad. Sci. USA, 77: 7417 (1980).Google Scholar
  3. 3.
    S. Broder, and R. C. Gallo, A pathogenic retrovirus (HTLV-III) linked to AIDS, N. Engl. J. Med., 311: 1292 (1984).PubMedCrossRefGoogle Scholar
  4. 4.
    M. Robert-Guroff, M. G. Sarngadharan, and R. C. Gallo, T-cell growth factor, in: “Growth and Maturation Factors”, G. Guroff (ed.), Vol. 2, John Wiley and Sons, Inc., New York, p. 267 (1984).Google Scholar
  5. 5.
    V. S. Kalyanaraman, M. G. Sarngadharan, M. Robert-Guroff, I. Miyoshi, D. Blayney, D. Golde, and R. C. Gallo, A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of Hairy Cell Leukemia, Science, 218: 571 (1982).PubMedCrossRefGoogle Scholar
  6. 6.
    M. Popovic, M. G. Sarngadharan, E. Read, and R. C. Gallo, Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS, Science, 224: 497 (1984).PubMedCrossRefGoogle Scholar
  7. 7.
    R. C. Gallo, S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan, B. F. Haynes, T. J. Palker, R. Redfield, J. Oleske, B. Salai, G. White, P. Foster, and P. D. Markham, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science, 224: 500 (1984).PubMedCrossRefGoogle Scholar
  8. 8.
    G. M. Shaw, B. H. Hahn, S. K. Arya, J. E. Groopman, R. C. Gallo, and F. Wong-Staal, Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome, Science, 226: 1165 (1984).PubMedCrossRefGoogle Scholar
  9. 9.
    D. Volkman, M. Popovic, R. C. Gallo, and A. Fauci, Human T-cell leukemia/lymphoma virus-infected antigen-specific T-cell clones: indiscriminant helper function and lymphokine production, J. Immunol., 134: 4237 (1985).PubMedGoogle Scholar
  10. 10.
    A. G. Fisher, E. Collalti, L. Ratner, R. C. Gallo, and F. Wong-Staal, A molecular clone of HTLV-III with biological activity, Nature, 316: 262 (1985).PubMedCrossRefGoogle Scholar
  11. 11.
    L. Ratner, W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, S. R. Petteway Jr., M. L. Pearson, J. A. Lautenberger, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal, Complete nucleotide sequence of the AIDS virus, HTLV-III, Nature, 313: 277 (1985).Google Scholar
  12. 12.
    W. A. Blattner, V. S. Kalyanaraman, M. Robert-Guroff, T. A. Kister, D. A. G. Galton, P. S. Sarin, M. H. Crawford, D. Catovsky, M. Greaves, and R. C. Gallo, The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma, Int. J. Cancer, 30:257 (1982).PubMedCrossRefGoogle Scholar
  13. 13.
    G. M. Shaw, M. E. Harper, B. H. Hahn, L. G. Epstein, D. C. Gajdusek, R. W. Price, B. A. Navia, C. K. Petito, C. J. O’Hara, J. E. Groopman, E.-S. Cho, J. M. Oleske, F. Wong-Staal, and R. C. Gallo, HTLV-III infection in brains of children and adults with AIDS encephalopathy, Science, 227: 177 (1985).PubMedCrossRefGoogle Scholar
  14. 14.
    J. W. Curran et al., The epidemiology of AIDS: Current Status and Future Projects, Science, 229: 1352 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Robert C. Gallo
    • 1
  • Flossie Wong-Staal
    • 1
  1. 1.Laboratory of Tumor Cell BiologyNIH, National Institute of CancerBethesdaUSA

Personalised recommendations